RecruitingNCT07388797

Impact of Serum Progesterone Levels on Embryo Transfer Day on Clinical Pregnancy

Impact of Serum Progesterone Levels on Embryo Transfer Day on Clinical Pregnancy in Frozen-thawed Embryo Transfer Cycles Using Hormone Replacement Therapy: a Prospective Observational Study


Sponsor

Chinese University of Hong Kong

Enrollment

370 participants

Start Date

Jan 20, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

Hypotheses: We hypothesize that serum progesterone levels on the day of embryo transfer in HRT-FET cycles are positively associated with clinical pregnancy rates. Aims: To evaluate the relationship between serum progesterone levels on embryo transfer day and clinical pregnancy outcomes in frozen-thawed embryo transfer cycles using hormone replacement therapy (HRT). Primary outcome: To compare the incidence of clinical pregnancy outcome in those infertility patients undergoing frozen embryo transfer with caterized Progesterone level on the day of embryo transfer Secondary outcomes: Biochemical pregnancy rate. Implantation rate. Early pregnancy loss rate. Ectopic pregnancy rate.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 42 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with reproductive issues. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

The Chinese University of Hong Kong

Hong Kong, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07388797


Related Trials